Loading…

Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes

Prostate cancer is the leading type of cancer diagnosed in men. In 2010, ∼217,730 new cases of prostate cancer were reported in the United States. Prompt diagnosis of the disease can substantially improve its clinical outcome. Improving capability for early detection, as well as developing new thera...

Full description

Saved in:
Bibliographic Details
Published in:Molecular & cellular proteomics 2012-10, Vol.11 (10), p.863-885
Main Authors: Hosseini-Beheshti, Elham, Pham, Steven, Adomat, Hans, Li, Na, Tomlinson Guns, Emma S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c443t-2f746f65812fe91ce293e9fd55ccbe9502fba2d39f34992ea4ef38c6055a68723
cites cdi_FETCH-LOGICAL-c443t-2f746f65812fe91ce293e9fd55ccbe9502fba2d39f34992ea4ef38c6055a68723
container_end_page 885
container_issue 10
container_start_page 863
container_title Molecular & cellular proteomics
container_volume 11
creator Hosseini-Beheshti, Elham
Pham, Steven
Adomat, Hans
Li, Na
Tomlinson Guns, Emma S.
description Prostate cancer is the leading type of cancer diagnosed in men. In 2010, ∼217,730 new cases of prostate cancer were reported in the United States. Prompt diagnosis of the disease can substantially improve its clinical outcome. Improving capability for early detection, as well as developing new therapeutic targets in advanced disease are research priorities that will ultimately lead to better patient survival. Eukaryotic cells secrete proteins via distinct regulated mechanisms which are either ER/Golgi dependent or microvesicle mediated. The release of microvesicles has been shown to provide a novel mechanism for intercellular communication. Exosomes are nanometer sized cup-shaped membrane vesicles which are secreted from normal and cancerous cells. They are present in various biological fluids and are rich in characteristic proteins. Exosomes may thus have potential both in facilitating early diagnosis via less invasive procedures or be candidates for novel therapeutic approaches for castration resistance prostate cancer. Because exosomes have been shown previously to have a role in cell-cell communication in the local tumor microenvironment, conferring activation of numerous survival mechanisms, we characterized constitutive lipids, cholesterol and proteins from exosomes derived from six prostate cell lines and tracked their uptake in both cancerous and benign prostate cell lines respectively. Our comprehensive proteomic and lipidomic analysis of prostate derived exosomes could provide insight for future work on both biomarker and therapeutic targets for the treatment of prostate cancer.
doi_str_mv 10.1074/mcp.M111.014845
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3494141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1535947620310513</els_id><sourcerecordid>1081872804</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-2f746f65812fe91ce293e9fd55ccbe9502fba2d39f34992ea4ef38c6055a68723</originalsourceid><addsrcrecordid>eNp1kU9vEzEQxVcIREvhzA35yCWp7bV31xyQShr-SKmIEJwtxzsmA7t2sJ1A-Sp8WRxtieDAybbmN28871XVU0bnjLbicrS7-Q1jbE6Z6IS8V50zWcuZKo_7p3vbnFWPUvpCKaeslQ-rM85bXtNOnVe_lj9CCiMkYhJ5hWE08StEsvQR7RZ6coM2hgMktAOkF2SxNdHYDBF_mozBk-DIpGAGso4hA_pErkv9UJpdDCMxZG08DEeyACmbDGQBw0BW6MvY75i35BpTRm8zufpA1lvwId_uID2uHjgzJHhyd15Un14vPy7ezlbv37xbXK1mVog6z7hrReMa2THuQDELXNWgXC-ltRtQknK3MbyvlauFUhyMAFd3tqFSmqYrRlxULyfd3X4zQm_B52gGvYtY3LjVwaD-t-Jxqz-Hgy56gglWBJ7fCcTwbQ8p6xGTLTuWxcM-aUY7VgZ1VBT0ckKLrSlFcKcxjOpjpLpEqo-R6inS0vHs79-d-D8ZFkBNABSPDghRJ4vgLfQYwWbdB_yv-G8uKbQ0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1081872804</pqid></control><display><type>article</type><title>Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes</title><source>PubMed (Medline)</source><source>ScienceDirect (Online service)</source><creator>Hosseini-Beheshti, Elham ; Pham, Steven ; Adomat, Hans ; Li, Na ; Tomlinson Guns, Emma S.</creator><creatorcontrib>Hosseini-Beheshti, Elham ; Pham, Steven ; Adomat, Hans ; Li, Na ; Tomlinson Guns, Emma S.</creatorcontrib><description>Prostate cancer is the leading type of cancer diagnosed in men. In 2010, ∼217,730 new cases of prostate cancer were reported in the United States. Prompt diagnosis of the disease can substantially improve its clinical outcome. Improving capability for early detection, as well as developing new therapeutic targets in advanced disease are research priorities that will ultimately lead to better patient survival. Eukaryotic cells secrete proteins via distinct regulated mechanisms which are either ER/Golgi dependent or microvesicle mediated. The release of microvesicles has been shown to provide a novel mechanism for intercellular communication. Exosomes are nanometer sized cup-shaped membrane vesicles which are secreted from normal and cancerous cells. They are present in various biological fluids and are rich in characteristic proteins. Exosomes may thus have potential both in facilitating early diagnosis via less invasive procedures or be candidates for novel therapeutic approaches for castration resistance prostate cancer. Because exosomes have been shown previously to have a role in cell-cell communication in the local tumor microenvironment, conferring activation of numerous survival mechanisms, we characterized constitutive lipids, cholesterol and proteins from exosomes derived from six prostate cell lines and tracked their uptake in both cancerous and benign prostate cell lines respectively. Our comprehensive proteomic and lipidomic analysis of prostate derived exosomes could provide insight for future work on both biomarker and therapeutic targets for the treatment of prostate cancer.</description><identifier>ISSN: 1535-9476</identifier><identifier>EISSN: 1535-9484</identifier><identifier>DOI: 10.1074/mcp.M111.014845</identifier><identifier>PMID: 22723089</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Cell Communication ; Cell Line, Tumor ; Cholesterol - analysis ; Chromatography, Liquid ; Cytoplasmic Vesicles - chemistry ; Exosomes - chemistry ; Gene Expression ; Humans ; Male ; Mass Spectrometry ; Microscopy, Electron, Transmission ; Neoplasm Proteins - genetics ; Neoplasm Proteins - metabolism ; Prostate - chemistry ; Prostate - pathology ; Prostatic Neoplasms - chemistry ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - pathology ; Receptors, Androgen - genetics ; Receptors, Androgen - metabolism ; Sphingolipids - analysis ; Tumor Microenvironment</subject><ispartof>Molecular &amp; cellular proteomics, 2012-10, Vol.11 (10), p.863-885</ispartof><rights>2012 © 2012 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>2012 by The American Society for Biochemistry and Molecular Biology, Inc. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-2f746f65812fe91ce293e9fd55ccbe9502fba2d39f34992ea4ef38c6055a68723</citedby><cites>FETCH-LOGICAL-c443t-2f746f65812fe91ce293e9fd55ccbe9502fba2d39f34992ea4ef38c6055a68723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494141/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1535947620310513$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22723089$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hosseini-Beheshti, Elham</creatorcontrib><creatorcontrib>Pham, Steven</creatorcontrib><creatorcontrib>Adomat, Hans</creatorcontrib><creatorcontrib>Li, Na</creatorcontrib><creatorcontrib>Tomlinson Guns, Emma S.</creatorcontrib><title>Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes</title><title>Molecular &amp; cellular proteomics</title><addtitle>Mol Cell Proteomics</addtitle><description>Prostate cancer is the leading type of cancer diagnosed in men. In 2010, ∼217,730 new cases of prostate cancer were reported in the United States. Prompt diagnosis of the disease can substantially improve its clinical outcome. Improving capability for early detection, as well as developing new therapeutic targets in advanced disease are research priorities that will ultimately lead to better patient survival. Eukaryotic cells secrete proteins via distinct regulated mechanisms which are either ER/Golgi dependent or microvesicle mediated. The release of microvesicles has been shown to provide a novel mechanism for intercellular communication. Exosomes are nanometer sized cup-shaped membrane vesicles which are secreted from normal and cancerous cells. They are present in various biological fluids and are rich in characteristic proteins. Exosomes may thus have potential both in facilitating early diagnosis via less invasive procedures or be candidates for novel therapeutic approaches for castration resistance prostate cancer. Because exosomes have been shown previously to have a role in cell-cell communication in the local tumor microenvironment, conferring activation of numerous survival mechanisms, we characterized constitutive lipids, cholesterol and proteins from exosomes derived from six prostate cell lines and tracked their uptake in both cancerous and benign prostate cell lines respectively. Our comprehensive proteomic and lipidomic analysis of prostate derived exosomes could provide insight for future work on both biomarker and therapeutic targets for the treatment of prostate cancer.</description><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Cell Communication</subject><subject>Cell Line, Tumor</subject><subject>Cholesterol - analysis</subject><subject>Chromatography, Liquid</subject><subject>Cytoplasmic Vesicles - chemistry</subject><subject>Exosomes - chemistry</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>Male</subject><subject>Mass Spectrometry</subject><subject>Microscopy, Electron, Transmission</subject><subject>Neoplasm Proteins - genetics</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Prostate - chemistry</subject><subject>Prostate - pathology</subject><subject>Prostatic Neoplasms - chemistry</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Receptors, Androgen - genetics</subject><subject>Receptors, Androgen - metabolism</subject><subject>Sphingolipids - analysis</subject><subject>Tumor Microenvironment</subject><issn>1535-9476</issn><issn>1535-9484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp1kU9vEzEQxVcIREvhzA35yCWp7bV31xyQShr-SKmIEJwtxzsmA7t2sJ1A-Sp8WRxtieDAybbmN28871XVU0bnjLbicrS7-Q1jbE6Z6IS8V50zWcuZKo_7p3vbnFWPUvpCKaeslQ-rM85bXtNOnVe_lj9CCiMkYhJ5hWE08StEsvQR7RZ6coM2hgMktAOkF2SxNdHYDBF_mozBk-DIpGAGso4hA_pErkv9UJpdDCMxZG08DEeyACmbDGQBw0BW6MvY75i35BpTRm8zufpA1lvwId_uID2uHjgzJHhyd15Un14vPy7ezlbv37xbXK1mVog6z7hrReMa2THuQDELXNWgXC-ltRtQknK3MbyvlauFUhyMAFd3tqFSmqYrRlxULyfd3X4zQm_B52gGvYtY3LjVwaD-t-Jxqz-Hgy56gglWBJ7fCcTwbQ8p6xGTLTuWxcM-aUY7VgZ1VBT0ckKLrSlFcKcxjOpjpLpEqo-R6inS0vHs79-d-D8ZFkBNABSPDghRJ4vgLfQYwWbdB_yv-G8uKbQ0</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Hosseini-Beheshti, Elham</creator><creator>Pham, Steven</creator><creator>Adomat, Hans</creator><creator>Li, Na</creator><creator>Tomlinson Guns, Emma S.</creator><general>Elsevier Inc</general><general>The American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20121001</creationdate><title>Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes</title><author>Hosseini-Beheshti, Elham ; Pham, Steven ; Adomat, Hans ; Li, Na ; Tomlinson Guns, Emma S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-2f746f65812fe91ce293e9fd55ccbe9502fba2d39f34992ea4ef38c6055a68723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Cell Communication</topic><topic>Cell Line, Tumor</topic><topic>Cholesterol - analysis</topic><topic>Chromatography, Liquid</topic><topic>Cytoplasmic Vesicles - chemistry</topic><topic>Exosomes - chemistry</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>Male</topic><topic>Mass Spectrometry</topic><topic>Microscopy, Electron, Transmission</topic><topic>Neoplasm Proteins - genetics</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Prostate - chemistry</topic><topic>Prostate - pathology</topic><topic>Prostatic Neoplasms - chemistry</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Receptors, Androgen - genetics</topic><topic>Receptors, Androgen - metabolism</topic><topic>Sphingolipids - analysis</topic><topic>Tumor Microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hosseini-Beheshti, Elham</creatorcontrib><creatorcontrib>Pham, Steven</creatorcontrib><creatorcontrib>Adomat, Hans</creatorcontrib><creatorcontrib>Li, Na</creatorcontrib><creatorcontrib>Tomlinson Guns, Emma S.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular &amp; cellular proteomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hosseini-Beheshti, Elham</au><au>Pham, Steven</au><au>Adomat, Hans</au><au>Li, Na</au><au>Tomlinson Guns, Emma S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes</atitle><jtitle>Molecular &amp; cellular proteomics</jtitle><addtitle>Mol Cell Proteomics</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>11</volume><issue>10</issue><spage>863</spage><epage>885</epage><pages>863-885</pages><issn>1535-9476</issn><eissn>1535-9484</eissn><abstract>Prostate cancer is the leading type of cancer diagnosed in men. In 2010, ∼217,730 new cases of prostate cancer were reported in the United States. Prompt diagnosis of the disease can substantially improve its clinical outcome. Improving capability for early detection, as well as developing new therapeutic targets in advanced disease are research priorities that will ultimately lead to better patient survival. Eukaryotic cells secrete proteins via distinct regulated mechanisms which are either ER/Golgi dependent or microvesicle mediated. The release of microvesicles has been shown to provide a novel mechanism for intercellular communication. Exosomes are nanometer sized cup-shaped membrane vesicles which are secreted from normal and cancerous cells. They are present in various biological fluids and are rich in characteristic proteins. Exosomes may thus have potential both in facilitating early diagnosis via less invasive procedures or be candidates for novel therapeutic approaches for castration resistance prostate cancer. Because exosomes have been shown previously to have a role in cell-cell communication in the local tumor microenvironment, conferring activation of numerous survival mechanisms, we characterized constitutive lipids, cholesterol and proteins from exosomes derived from six prostate cell lines and tracked their uptake in both cancerous and benign prostate cell lines respectively. Our comprehensive proteomic and lipidomic analysis of prostate derived exosomes could provide insight for future work on both biomarker and therapeutic targets for the treatment of prostate cancer.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22723089</pmid><doi>10.1074/mcp.M111.014845</doi><tpages>23</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1535-9476
ispartof Molecular & cellular proteomics, 2012-10, Vol.11 (10), p.863-885
issn 1535-9476
1535-9484
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3494141
source PubMed (Medline); ScienceDirect (Online service)
subjects Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Cell Communication
Cell Line, Tumor
Cholesterol - analysis
Chromatography, Liquid
Cytoplasmic Vesicles - chemistry
Exosomes - chemistry
Gene Expression
Humans
Male
Mass Spectrometry
Microscopy, Electron, Transmission
Neoplasm Proteins - genetics
Neoplasm Proteins - metabolism
Prostate - chemistry
Prostate - pathology
Prostatic Neoplasms - chemistry
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - pathology
Receptors, Androgen - genetics
Receptors, Androgen - metabolism
Sphingolipids - analysis
Tumor Microenvironment
title Exosomes as Biomarker Enriched Microvesicles: Characterization of Exosomal Proteins Derived from a Panel of Prostate Cell Lines with Distinct AR Phenotypes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A40%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exosomes%20as%20Biomarker%20Enriched%20Microvesicles:%20Characterization%20of%20Exosomal%20Proteins%20Derived%20from%20a%20Panel%20of%20Prostate%20Cell%20Lines%20with%20Distinct%20AR%20Phenotypes&rft.jtitle=Molecular%20&%20cellular%20proteomics&rft.au=Hosseini-Beheshti,%20Elham&rft.date=2012-10-01&rft.volume=11&rft.issue=10&rft.spage=863&rft.epage=885&rft.pages=863-885&rft.issn=1535-9476&rft.eissn=1535-9484&rft_id=info:doi/10.1074/mcp.M111.014845&rft_dat=%3Cproquest_pubme%3E1081872804%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-2f746f65812fe91ce293e9fd55ccbe9502fba2d39f34992ea4ef38c6055a68723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1081872804&rft_id=info:pmid/22723089&rfr_iscdi=true